AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 195 filers reported holding AXSOME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,616,920 | -56.4% | 80,368 | -55.2% | 0.35% | -58.1% |
| Q2 2023 | $12,880,330 | +72.7% | 179,242 | +48.3% | 0.84% | +76.9% |
| Q1 2023 | $7,456,865 | +97.4% | 120,896 | +20.9% | 0.48% | +115.8% |
| Q4 2021 | $3,778,000 | -47.2% | 100,000 | +15.0% | 0.22% | -51.0% |
| Q2 2020 | $7,156,000 | +66.3% | 86,978 | +18.9% | 0.45% | +13.3% |
| Q1 2020 | $4,304,000 | – | 73,163 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |